Home › Calculator › GTBP Dividend Calculator 2026
GTBP Dividend Calculator 2026
No dividendHealthcareGT Biopharma, Inc. · NASDAQ
Price: $5.07 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
GTBP is not a dividend-focused stock
GTBP pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
GTBP Dividend Yield
GT Biopharma, Inc. (GTBP) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GTBP pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About GT Biopharma, Inc. (GTBP) — Dividend Analysis 2026
GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers on a proprietary technology platform called Tri-specific Killer Engager (TriKE) fusion proteins, which are designed to harness the body's immune cells. Central to their pipeline is GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate currently undergoing Phase I/II clinical trials. This therapeutic candidate is being evaluated for its potential in treating myelodysplastic syndromes, acute myeloid leukemia that has relapsed or proven refractory to prior treatments, advanced systemic mastocytosis, and other malignancies expressing CD33. The company's research also includes GTB-3650, which is in preclinical development targeting CD33 on myeloid leukemias, and GTB-5550, another preclinical asset aimed at solid tumors that are positive for B7-H3. GT Biopharma has forged key collaborations, including a co-development agreement with Altor BioScience Corporation for the clinical advancement of a 161533 TriKE fusion protein for various cancer indications. Furthermore, they maintain a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies utilizing their TriKE technology. Founded in 1965, the company previously operated as OXIS International, Inc. before rebranding to GT Biopharma, Inc. in July 2017. Its corporate operations are based in Brisbane, California.
GTBP Dividend & DRIP — Frequently Asked Questions
Does GTBP pay a dividend?
No. GT Biopharma, Inc. (GTBP) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of GTBP?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does GTBP have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. GTBP has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to GTBP
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GTBP DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GTBP position with:
🌍 GTBP Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GTBP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GTBP Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GTBP Dividend Payment Schedule
GTBP pays quarterly — 4 times per year. Ex-div: —.
📊 GTBP vs Healthcare Benchmarks
How GTBP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GTBP sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GTBP Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-09-04 | 31,250 | $1.33 | $41.6K | ||
| A-Award | 2025-09-04 | 100,000 | $1.33 | $133.0K | ||
| A-Award | 2025-09-04 | 50,000 | $1.33 | $66.5K | ||
| A-Award | 2025-09-04 | 62,500 | $1.33 | $83.1K | ||
| A-Award | 2025-09-04 | 31,250 | $1.33 | $41.6K | ||
| A-Award | 2024-10-17 | 23,335 | $2.11 | $49.2K | ||
| A-Award | 2023-08-11 | 200,000 | $0.29 | $57.4K | ||
| J-Other | 2023-08-11 | 200,000 | $0.29 | $57.4K | ||
| A-Award | 2023-08-11 | 200,000 | $0.29 | $57.4K | ||
| J-Other | 2023-08-11 | 200,000 | $0.29 | $57.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare GTBP with peers: GTBP vs ARTL · GTBP vs CARM · GTBP vs DRMA
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GTBP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
GT Biopharma, Inc. (GTBP) is currently trading at $5.07, trading near its 52-week low. It does not currently pay a regular dividend.
Does GTBP Pay a Dividend? GT Biopharma, Inc. Dividend Status
GT Biopharma, Inc. (GTBP) is a healthcare stock trading at $5.07. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest GTBP News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your GTBP DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.